Neutrophil-activating peptide 1/interleukin 8 mRNA expression and protein secretion by human monocytes: Effect of cyclosporin A
- 1 July 1991
- Vol. 3 (4) , 322-326
- https://doi.org/10.1016/1043-4666(91)90500-d
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- CyclosporineNew England Journal of Medicine, 1989
- Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.Journal of Clinical Investigation, 1989
- The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate.The Journal of Experimental Medicine, 1989
- Identification of Two Endogenous Neutrophil-Activating Peptides in Psoriatic Skin and Inflammatory Cells: C5ades arg and NAPDermatology, 1989
- Comparison of patterns of expression of tumour necrosis factor, lymphotoxin and interleukin-6 MRNABiochemical and Biophysical Research Communications, 1988
- Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor.The Journal of Experimental Medicine, 1988
- INHIBITION OF HUMAN MONOCYTE ANTIGEN PRESENTATION, BUT NOT HLA-DR EXPRESSION, BY CYCLOSPORINETransplantation, 1987
- Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.The Journal of Experimental Medicine, 1987
- Identification of C5ades arg and an Anionic Neutrophil-Activating Peptide (ANAP) in Psoriatic ScalesJournal of Investigative Dermatology, 1986
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981